CLINICAL PHARMACOLOGY OF ANTINEOPLASTIC AGENTS .2.

被引：111

作者：

CHABNER, BA ^{[1
]}

MYERS, CE ^{[1
]}

COLEMAN, N ^{[1
]}

JOHNS, DG ^{[1
]}

机构：

[1] NCI,LAB CHEM PHARMACOL,BLDG 10,ROOM 6N110,BETHESDA,MD 20014

来源：

关键词：

D O I：

10.1056/NEJM197505292922206

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1159 / 1168

页数：10

共 103 条

[1] FORMATION OF CYTOTOXIC ALDEHYDE ACROLEIN DURING IN-VITRO DEGRADATION OF CYCLOPHOSPHAMIDE
ALARCON, RA
MEIENHOF.J
[J]. NATURE-NEW BIOLOGY, 1971, 233 (42): : 250 - &
[2] ARENA E, 1972, INT S ADRIAMYCIN, P96
[3] NEUARTIGE KREBS-CHEMOTHERAPEUTIKA AUS DER GRUPPE DER ZYKLISCHEN N-LOST-PHOSPHAMIDESTER
ARNOLD, H
BOURSEAUX, F
BROCK, N
[J]. NATURWISSENSCHAFTEN, 1958, 45 (03) : 64 - 66
[4] GE++ SYNTHESIS AND BREAKDOWN OF CYTOSTATICALLY ACTIVE N-PHOSPHAMIDE ESTERS OF THE BIS-(BETA-CHLORETHYL)-AMINE
ARNOLD, H
BOURSEAUX, F
[J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1958, 70 (17-8) : 539 - 544
[5] MASSIVE HEPATIC NECROSIS AFTER CYCLOPHOSPHAMIDE
AUBREY, DA
[J]. BRITISH MEDICAL JOURNAL, 1970, 3 (5722) : 588 - &
[6] BARRANCO SC, 1971, CANCER RES, V31, P1218
[7] BEDROSSIAN CW, 1973, CANCER-AM CANCER SOC, V32, P44, DOI 10.1002/1097-0142(197307)32:1<44::AID-CNCR2820320106>3.0.CO
[8] 2-Q
[9] BENJAMIN RS, 1974, CANCER, V33, P19, DOI 10.1002/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO
[10] 2-M